Interpace Diagnostics Gr Q1 Adj. EBITDA Loss $900K vs Loss $4.3M In Same Qtr. Last Year, Sales $9.80M Up From $9.20M YoY
Benzinga Newsdesk 5 years ago
EarningsNews
Interpace Diagnostics Gr (NASDAQ:IDXG) reported $9.80 million in sales this quarter. This is a 6.52 percent increase over sales of $9.20 million the same period last year.
Interpace Diagnostics Gr (NASDAQ:IDXG) reported $9.80 million in sales this quarter. This is a 6.52 percent increase over sales of $9.20 million the same period last year.